Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007
Published online before print October 25, 2007, doi: 10.1161/CIRCRESAHA.107.161711
A more recent version of this article appeared on January 4, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
102/1/113    most recent
CIRCRESAHA.107.161711v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Out, R.
Right arrow Articles by Van Eck, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Out, R.
Right arrow Articles by Van Eck, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Genetically altered mice

Submitted on August 10, 2007
Revised on October 2, 2007
Accepted on October 17, 2007

Coexistence of Foam Cells and Hypocholesterolemia in Mice Lacking the ABC Transporters A1 and G1

Ruud Out *; Wendy Jessup ; Wilfried Le Goff ; Menno Hoekstra ; Ingrid C. Gelissen ; Ying Zhao ; Leonard Kritharides ; Giovanna Chimini ; Johan Kuiper ; M. John Chapman ; Thierry Huby ; Theo J.C. Van Berkel ; and Miranda Van Eck

From the Division of Biopharmaceutics 9R.O., M.H., Y.Z., J.K., T.J.C.V.B., M.V.E.), Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands; the Centre for Vascular Research (W.J., I.C.G., L.K.), School of Medical Sciences, University of New South Wales, Sydney, Australia; INSERM U551 (W.L.g., M.J.C., T.H.), Paris, France; Université Pierre et Marie Curie-Paris6 (W.L.G., M.J.C., T.H.), UMR S551 Paris, France; and Centre d'Immunologie de Marseille Luminy (G.C.), Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Université de la Méditerranée, Marseille, France.

* To whom correspondence should be addressed. E-mail: r.out{at}lacdr.leidenuniv.nl.

The concept that macrophages can become foam cells as a result of a disturbed balance between the uptake of cholesterol from lipoproteins and cholesterol efflux is generally accepted. ABCA1 and ABCG1 are two cholesterol transporters that may act sequentially to remove cellular cholesterol, but currently their combined role in vivo is unknown. We report here that targeted disruption of both ABCA1 and ABCG1 in mice, despite severe plasma hypocholesterolemia, leads to massive lipid accumulation and foam cell formation of tissue macrophages. A complete ablation of cellular cholesterol efflux in vitro is observed, whereas in vivo macrophage-specific reverse cholesterol transport to the feces is markedly decreased. Despite the massive foam cell formation of tissue macrophages, no lipid accumulation was observed in the vascular wall, even in mice of 1 year old, indicating that the double knockout mice, possibly because of their hypocholesterolemia, lack the trigger to attract macrophages to the vessel wall. In conclusion, even under hypocholesterolemic conditions macrophages can be converted into foam cells, and ABCA1 and ABCG1 play an essential role in the prevention of foam cell formation.


Key words: ABC transporter • reverse cholesterol transport • cholesterol efflux • macrophage • foam cell




This article has been cited by other articles:


Home page
JAMAHome page
R. Frikke-Schmidt, B. G. Nordestgaard, M. C. A. Stene, A. A. Sethi, A. T. Remaley, P. Schnohr, P. Grande, and A. Tybjaerg-Hansen
Association of Loss-of-Function Mutations in the ABCA1 Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease
JAMA, June 4, 2008; 299(21): 2524 - 2532.
[Abstract] [Full Text] [PDF]